On a mission to defend more stroke patients from a life of disability, Stanford Medicine colleagues drive research that extends the window for effective intervention.
Stanford researchers have developed a synthetic, tumor-targeting molecule that promotes immune activation and tumor regression in mice.
A leader in the biomedical revolution, Stanford Medicine has a long tradition of leadership in pioneering research, creative teaching protocols and effective clinical therapies.
Data suggest that between 10% and 30% of those who have had an acute SARS-CoV-2 infection will experience the persistent pattern of symptoms known as long COVID.
A Stanford doctor helped write and support legislation to enable free hepatitis B and C screenings for those who request it.
New medications help many people with inflammatory conditions and may ease severe COVID-19, but they carry risks.
Michele Barry, MD, explains how the medical community is at the center of the climate change debate.
A Stanford neurosurgeon developed a glove that delivers vibratory bursts of electricity to the fingertips to quell Parkinson's symptoms.
